{"SPADE_UN_17672": {"Clinical Information": [], "Patent Information": [{"Patent No": "US8431396B2", "Patent Link": "http://www.lens.org/lens/patent/US8431396B2", "Patent Type": "Granted Patent", "Publication Date": "2013-4-13", "Family Info": "Notavailable", "Patent Title": "Anti-angiogenic peptides", "Abstract": "A purified polypeptide includes about 10 to about 40 amino acids and has an amino acid sequence corresponding to a portion of SEQ ID NO: 2. The polypeptide can inhibit binding of VEGF to VEGFR2 of cells that express VEGFR2."}], "Sequence Information": {"SPADE ID": "SPADE_UN_17672", "Sequence": "ECLWMDWVTEKNINGHQAKFFACI", "Sequence Length": 24, "Peptide Name": "Loop 6", "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Frequent Amino Acids": "ACE", "Absent Amino Acids": "OPRSUY", "Basic Residues": 3, "Acidic Residues": 3, "Hydrophobic Residues": 11, "Polar Residues": 12, "Positive Residues": 3, "Negative Residues": 3, "Mass": 2884.31, "PI": 5.45, "Net Charge": 0, "Hydrophobicity": -0.08, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17668", "Similarity": 1.0, "Sequence": "CKITRCPMIPCYISSPDECLWMDWVTEKNINGHQAKFFAC"}, {"SPADE_ID": "SPADE_UN_17669", "Similarity": 1.0, "Sequence": "CKITRCPMIPCYISSPDECLWMDWVTEKNINGHQAKFFACIKRSDGSC"}, {"SPADE_ID": "SPADE_UN_17670", "Similarity": 1.0, "Sequence": "CLWMDWVTEKNINGHQAKFFAC"}]}}}